Fabry Disease: A Focus on the Role of Oxidative Stress
Antioxidants · 26.01.2026 · 15 (2) · 168
DOI: 10.3390/antiox15020168 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 26.01.2026. Verfasst von Julia Rydzek und 6 weiteren Autor:innen. Beteiligte Einrichtung: Student Scientific Society Anatomia-Klinika Nauka, Division of Anatomy, Department of Human Morphology and Embryology, Wroclaw Medical University, 50…. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Fabry disease is an X-linked lysosomal storage disorder caused by mutations in the GLA gene, leading to α-galactosidase A deficiency, accumulation of globotriaosylceramide (Gb3), and progressive multiorgan involvement. Increasing evidence indicates that oxidative stress plays a central role in disease pathogenesis. This review aims to synthesize current knowledge on the molecular mechanisms underlying oxidative stress, the relevance of oxidative damage biomarkers, and potential therapeutic implications. A comprehensive literature search was conducted in PubMed/MEDLINE, Scopus, Web of Science, and Google Scholar using terms related to Fabry disease, Gb3 metabolism, mitochondrial and endothelial dysfunction, inflammatory signaling, and oxidative stress markers. Clinical, experimental, and translational studies were included. Available data demonstrate that Gb3 accumulation disrupts mitochondrial function and activates NADPH oxidase, NF-κB, and MAPK signaling pathways, resulting in excessive production of reactive oxygen species. These processes contribute to cellular injury, particularly within the cardiovascular, renal, and nervous systems. Biomarkers such as malondialdehyde, 8-hydroxy-2′-deoxyguanosine, glutathione redox status, and antioxidant enzyme activities appear useful for assessing oxidative burden and monitoring therapeutic responses. Overall, current evidence underscores the pivotal role of oxidative stress in the progression of Fabry disease and highlights the need for further research into targeted antioxidant and disease-modifying therapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Student Scientific Society Anatomia-Klinika Nauka, Division of Anatomy, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-367 Wroclaw, Poland.
- Division of Anatomy, Department of Human Morphology and Embryology, Wroclaw Medical University, 50-367 Wroclaw, Poland.
ORCID-Profile: Julia Rydzek, Julia Soczyńska, Wiktor Gawełczyk, Mateusz Żołyniak, Sławomir Woźniak
Zitieren
APA
Rydzek, J., Muzyka, A., Majcherczyk, K., Soczyńska, J., Gawełczyk, W., Żołyniak, M., & Woźniak, S. (2026). Fabry Disease: A Focus on the Role of Oxidative Stress. Antioxidants, 15(2), 168. https://doi.org/10.3390/antiox15020168
Vancouver
Rydzek J, Muzyka A, Majcherczyk K, Soczyńska J, Gawełczyk W, Żołyniak M, et al. Fabry Disease: A Focus on the Role of Oxidative Stress. Antioxidants. 2026;15(2):168. doi:10.3390/antiox15020168
BibTeX
@article{Rydzek2026,
author = {Rydzek, Julia and Muzyka, Adrian and Majcherczyk, Krzysztof and Soczyńska, Julia and Gawełczyk, Wiktor and Żołyniak, Mateusz and Woźniak, Sławomir},
title = {Fabry Disease: A Focus on the Role of Oxidative Stress},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {2},
pages = {168},
doi = {10.3390/antiox15020168}
}
EUVIMED